Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
CALL
Morgan Stanley
MS
$336B
| $650M | 0.09% |
7,091,800
+1,092,600
| +18% | +$93.7M |
|
177
CALL
Intuitive Surgical
ISRG
$134B
| $643M | 0.09% |
2,099,100
+179,700
| +9% | +$50.4M |
|
178
CALL
AT&T
T
$173B
| $636M | 0.09% |
29,266,888
-10,599,282
| -27% | -$241M |
|
179
CALL
Comcast
CMCSA
$95.3B
| $633M | 0.09% |
11,092,800
+29,900
| +0.3% | +$1.67M |
|
180
CALL
Teladoc Health
TDOC
$1.16B
| $630M | 0.09% |
3,791,500
+1,012,500
| +36% | +$164M |
|
|
PARA
181
PUT
DELISTED
Paramount Global Class B
PARA
| $629M | 0.09% |
13,918,900
-3,207,000
| -19% | -$132M |
|
182
CALL
Lowe's Companies
LOW
$121B
| $626M | 0.09% |
3,226,200
+1,025,800
| +47% | +$201M |
|
183
PUT
Pfizer
PFE
$160B
| $625M | 0.09% |
15,972,500
-32,800
| -0.2% | -$1.28M |
|
184
PUT
General Motors
GM
$77.2B
| $623M | 0.09% |
10,535,700
+2,191,300
| +26% | +$129M |
|
|
185
PUT
Morgan Stanley
MS
$336B
| $621M | 0.09% |
6,772,800
-770,900
| -10% | -$66.1M |
|
186
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $616M | 0.09% |
1,102,800
-194,000
| -15% | -$98.3M |
|
187
CALL
United States Oil Fund
USO
$2.24B
| $612M | 0.09% |
12,277,200
+531,300
| +5% | +$24M |
|
188
CALL
Twilio
TWLO
$34.6B
| $609M | 0.09% |
1,543,900
-91,600
| -6% | -$31.8M |
|
189
CALL
iShares MSCI Brazil ETF
EWZ
$8.52B
| $607M | 0.09% |
14,982,100
+814,200
| +6% | +$30.7M |
|
190
PUT
Blackrock
BLK
$179B
| $602M | 0.08% |
688,500
+228,700
| +50% | +$193M |
|
191
PUT
ARK Innovation ETF
ARKK
$6.72B
| $602M | 0.08% |
4,599,500
-317,000
| -6% | -$36.9M |
|
192
CALL
Lockheed Martin
LMT
$130B
| $600M | 0.08% |
1,586,300
+16,100
| +1% | +$6.19M |
|
|
193
CALL
Pfizer
PFE
$160B
| $597M | 0.08% |
15,248,300
-4,298,000
| -22% | -$167M |
|
194
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$14.3B
| $590M | 0.08% |
7,569,500
-3,415,500
| -31% | -$248M |
|
|
195
AT&T
T
$173B
| $588M | 0.08% |
27,046,385
+7,746,502
| +40% | +$176M |
|
196
PUT
Uber
UBER
$161B
| $584M | 0.08% |
11,657,500
+3,812,200
| +49% | +$199M |
|
197
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $583M | 0.08% |
4,297,600
-220,900
| -5% | -$29M |
|
198
CALL
Chevron
CVX
$403B
| $582M | 0.08% |
5,560,400
-195,900
| -3% | -$20.7M |
|
|
199
PUT
Intuitive Surgical
ISRG
$134B
| $579M | 0.08% |
1,887,300
+5,400
| +0.3% | +$1.51M |
|
200
CALL
United Parcel Service
UPS
$86.8B
| $576M | 0.08% |
2,768,300
-827,800
| -23% | -$166M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,175 increased, 5,390 reduced and 1,328 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,328 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.